Archive Links
Reimburse Calendar
NFOG Educational Course 2010: Polycystic Ovary Syndrome Through Life

Final announcement

Print

 

Below you will find links to presentations or articles reviewing the topics.
(All posted with permission by the authors)

The NFOG Educational Committee hereby invites you to the NFOG Specialist Course on
Polycystic Ovary Syndrome through Life
. The course will deal with aspects of PCOS related to different ages and endocrine states of a woman´s life. Nordic and international top speakers with active research in this area will participate. The course is the second NFOG Specialist Course , planned to run each year with different topics, and aimed at specialists in Obstetrics and Gynecology, but also trainees.

Below you find the final program. The number of participants is limited to 200, due to course facilities. NFOG members (includes all members of the national societies) are welcome to register at the NFOG web-site from now on. Non-members are welcome to register from September 15 th . Reservations at different hotels in the area could be made at the same time as the registration. The course will be sponsored according to regulations by the Danish Legal Board of Self-Regulation concerning Pharmaceuticals.

Welcome!
Marie Bixo and Eszter Vanky
NFOG Educational Committee and local organizers

 

Dates:
November 17th – 18th 2010
Language: English
Venue:

Park Inn Copenhagen Airport Hotel, Engvej 171, Copenhagen, (Check googlemaps)

 

 

Wednesday November 17th
  11.30 – 13.00

REGISTRATION, LUNCH

 
  13.00 – 13.05

Welcome and introduction

President of NFOG
Session 1 Prenatal and early development and treatment of PCOS
  13.05 – 13.30

Intrauterine environment and PCOS

Sven M. Carlsen Professor MD (N)
  13.30 – 14.00

Early development & pubertal prevention of PCOS (articles):

Early Origins of Polycystic Ovary Syndrome:
Hypotheses May Change without Notice

Adipose tissue expandability and
the early origins of PCOS

 

Francis de Zegher Professor MD (B)
  14.00 – 14.30

Treatment of PCOS in adolescence (articles):


Metformin Treatment for Four Years to Reduce Total and Visceral Fat in Low Birth Weight Girls with Precocious Pubarche


Early metformin therapy to delay menarche and augment height in girls with precocious pubarche

Early Development of Visceral Fat Excess
after Spontaneous Catch-Up Growth in
Children with Low Birth Weight


Pubertal Metformin Therapy to Reduce Total, Visceral, and Hepatic Adiposity

Ethinylestradiol-Drospirenone, Flutamide-Metformin, or Both for Adolescents and Women with Hyperinsulinemic
Hyperandrogenism: Opposite Effects on Adipocytokines and Body Adiposity

Flutamide-Metformin plus Ethinylestradiol-
Drospirenone for Lipolysis and antiatherogenesis in Young Women with Ovarian Hyperandrogenism: The Key Role of Metformin at the Start and after More than
One Year of Therapy

Combined Low-Dose Pioglitazone, Flutamide, and Metformin for Women with Androgen Excess

Pioglitazone (7·5 mg/day) added to flutamide–metformin in women with androgen excess: additional increments of
visfatin and high molecular weight adiponectin

Lourdes Ibanez MD, PhD (E)
  14.30 – 14.50

Panel discussion and questions

 
  14.50 - 15.20

COFFEE

 
Session 2 PCOS, pregnancy and metformin  
  15.20 – 15.50

Metformin and ART in PCOS: A RCT

Sigrun Kjøtrød , MD PhD (N)
  15.50 – 16.20 Metformin in early pregnancy and abortions Laure Morin-Papunen, MD PhD (SF)
  16.20 – 16.50 Metformin and pregnancy outcome in PCOS Eszter Vanky, MD PhD (N)
  16.50 – 17.20 Panel discussion and questions  
  19.00 DINNER  
Thursday November 18th
Session 3 PCOS in the adult woman  
  08.30 – 08.50

PCOS, obesity in the young adult

Ditte Trolle MD PhD (DK)
  08.50 – 09.10

Metformin: When and to whom?

Ditte Trolle MD PhD(DK)
  09.10 – 09.30

Diet and lifestyle

Angelica Linden-Hirschberg MD Professor (S)
  09.30 – 09.50

Are there any benefits of PCOS?

Angelica Linden-Hirschberg MD Professor (S)
  09.50 – 10.10 Panel discussion and questions  
  10.10 – 10.40

COFFEE

 
Session 4 Quality of life – later in life  
  10.40 – 11.10

Quality of life in PCOS

Speaker changed.
  11.10 – 11.40

Cardiovascular risk factors

Harpal Randeva MD Professor (UK)
  11.40 – 12.00

Diabetes and PCOS

Sven M. Carlsen MD Professor (N)
  12.00 – 12.30

Premenopausal PCOS – symptoms and consequences

Inger Sundström-Poromaa, MD, Professor (S)
  12.30 – 13.00

Panel discussion and questions

 
  13.00 – 13.05 Concluding remarks NFOG Educational Committee
  13.05 LUNCH  
   
Organiser: NFOG Educational Committee

Marie Bixo and Eszter Vanky

Contact: education@nfog.org